Tumor-derived exosomes in cancer progression and treatment failure

por Yu, Shaorong, Cao, Haixia, Shen, Bo, Feng, Jifeng
Publicado en Oncotarget (2015)

Comparative analysis of microRNA expression profiles between A549, A549/DDP and their respective exosomes

por Qin, Xiaobing, Yu, Shaorong, Xu, Xiaoyue, Shen, Bo, Feng, Jifeng
Publicado en Oncotarget (2017)

Immunotherapy strategy of EGFR mutant lung cancer

por Yu, Shaorong, Liu, Delin, Shen, Bo, Shi, Meiqi, Feng, Jifeng
Publicado en Am J Cancer Res (2018)

Colorectal Cancer Patients with Low Abundance of KRAS Mutation May Benefit from EGFR Antibody Therapy

por Yu, Shaorong, Xiao, Xia, Lu, Jianwei, Qian, Xiaoping, Liu, Baorui, Feng, Jifeng
Publicado 2013

Comparison of nedaplatin-based versus cisplatin-based chemotherapy for advanced non-small cell lung cancer among East Asian populations: A meta-analysis

por Liu, Yun, Yu, Shaorong, Liu, Siwen, Cao, Haixia, Ma, Rong, Wu, Jianzhong, Feng, Jifeng
Publicado en Sci Rep (2015)

miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway

por Shen, Bo, Yu, Shaorong, Zhang, Yan, Yuan, Yuan, Li, Xiaoyou, Zhong, Jian, Feng, Jifeng
Publicado en Onco Targets Ther (2016)

Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation

por Gao, Jin, Yuan, Yuan, Zhang, Lili, Yu, Shaorong, Lu, Jianwei, Feng, Jifeng, Hu, Sainan
Publicado en Cancer Cell Int (2020)

Screening TCGA database for prognostic genes in lower grade glioma microenvironment

por Ni, Jie, Liu, Siwen, Qi, Feng, Li, Xiao, Yu, Shaorong, Feng, Jifeng, Zheng, Yuxiao
Publicado en Ann Transl Med (2020)

Retraction Note to: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation

por Gao, Jin, Yuan, Yuan, Zhang, Lili, Yu, Shaorong, Lu, Jianwei, Feng, Jifeng, Hu, Sainan
Publicado en Cancer Cell Int (2021)

Immune checkpoint inhibitors combined with chemotherapy/bevacizumab therapy for patients with advanced lung cancer and heavily treated with EGFR mutation: a retrospective analysis

por Hu, Ran, Zhao, Zhiting, Shi, Yue, Shi, Meiqi, Xia, Guohao, Yu, Shaorong, Feng, Jifeng
Publicado en J Thorac Dis (2021)

A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy

por Wu, Ranpu, Yu, Shaorong, Ye, Jinjun, Wang, Yimin, Zhao, Zhiting, Liu, Hongbing, Song, Yong
Publicado en Front Oncol (2021)

Exosomes: Decreased Sensitivity of Lung Cancer A549 Cells to Cisplatin

por Xiao, Xia, Yu, Shaorong, Li, Shuchun, Wu, Jianzhong, Ma, Rong, Cao, Haixia, Zhu, Yanliang, Feng, Jifeng
Publicado 2014

Exosome-mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR-21

por Jing, Changwen, Cao, Haixia, Qin, Xiaobing, Yu, Shaorong, Wu, Jianzhong, Wang, Zhuo, Ma, Rong, Feng, Jifeng
Publicado en Oncol Lett (2018)

Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia

por Ni, Jie, Wu, Yang, Qi, Feng, Li, Xiao, Yu, Shaorong, Liu, Siwen, Feng, Jifeng, Zheng, Yuxiao
Publicado en Front Oncol (2020)

Paclitaxel-resistant gastric cancer MGC-803 cells promote epithelial-to-mesenchymal transition and chemoresistance in paclitaxel-sensitive cells via exosomal delivery of miR-155-5p

por Wang, Mei, Qiu, Rong, Yu, Shaorong, Xu, Xiaoyue, Li, Gang, Gu, Rongmin, Tan, Caihong, Zhu, Wei, Shen, Bo
Publicado en Int J Oncol (2018)

Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR‐TKI treatment

por Cao, Haixia, Yu, Shaorong, Chen, Dan, Jing, Changwen, Wang, Zhuo, Ma, Rong, Liu, Siwen, Ni, Jie, Feng, Jifeng, Wu, Jianzhong
Publicado en FEBS Open Bio (2016)

Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner

por Qin, Xiaobing, Yu, Shaorong, Zhou, Leilei, Shi, Meiqi, Hu, Yong, Xu, Xiaoyue, Shen, Bo, Liu, Siwen, Yan, Dali, Feng, Jifeng
Publicado en Int J Nanomedicine (2017)

Knockdown of lncRNA TUC338 inhibits esophageal cancer cells migration and invasion

por Qian, Ting, Zhang, Hui, Yu, Shaorong, Chen, Zhenzhang, Jia, Hui, Peng, Fanyu, Cao, Guochun, Lu, Jianwei, Liu, Delin, Sun, Dawei
Publicado en J Thorac Dis (2021)

Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of...

por Hu, Yong, Zang, Jialan, Qin, Xiaobing, Yan, Dali, Cao, Haixia, Zhou, Leilei, Ni, Jie, Yu, Shaorong, Wu, Jianzhong, Feng, Ji-Feng
Publicado en Onco Targets Ther (2017)

LXR ligands induce apoptosis of EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt-NF-κB activation

por Liu, Siwen, Cao, Haixia, Chen, Dan, Yu, Shaorong, Sha, Huanhuan, Wu, Jianzhong, Ma, Rong, Wang, Zhuo, Jing, Changwen, Zhang, Junying, Feng, Jifeng
Publicado en Oncol Lett (2018)